D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Infosys
INFY
$70.3B
| $1.61M | ﹤0.01% |
146,911
+125,211
| +577% | +$1.37M |
|
1627
Carpenter Technology
CRS
$12B
| $1.6M | ﹤0.01% |
34,918
-19,373
| -36% | -$888K |
|
|
FTR
1628
DELISTED
Frontier Communications Corp.
FTR
| $1.6M | ﹤0.01% |
804,716
+746,242
| +1,276% | +$1.48M |
|
1629
United Bankshares
UBSI
$5.3B
| $1.6M | ﹤0.01% |
44,008
-9,726
| -18% | -$353K |
|
|
BAS
1630
DELISTED
Basis Energy Services, Inc.
BAS
| $1.59M | ﹤0.01% |
417,428
+34,040
| +9% | +$129K |
|
1631
Marriott Vacations Worldwide
VAC
$2.67B
| $1.57M | ﹤0.01% |
16,799
-376,028
| -96% | -$35.2M |
|
1632
Mammoth Energy Services
TUSK
$114M
| $1.56M | ﹤0.01% |
93,945
-13,374
| -12% | -$223K |
|
1633
Diamondback Energy
FANG
$39.6B
| $1.56M | ﹤0.01% |
15,381
-36,367
| -70% | -$3.69M |
|
1634
WaFd
WAFD
$2.46B
| $1.55M | ﹤0.01% |
53,710
-13,439
| -20% | -$388K |
|
|
LX
1635
LexinFintech Holdings
LX
$961M
| $1.55M | ﹤0.01% |
+147,683
| New | +$1.55M |
|
1636
Luxfer Holdings
LXFR
$356M
| $1.55M | ﹤0.01% |
62,029
-28,653
| -32% | -$716K |
|
1637
SEACOR Marine Holdings
SMHI
$180M
| $1.55M | ﹤0.01% |
116,391
-1,320
| -1% | -$17.6K |
|
1638
Financial Institutions
FISI
$545M
| $1.55M | ﹤0.01% |
56,819
-8,341
| -13% | -$227K |
|
|
LION
1639
DELISTED
Fidelity Southern Corporation
LION
| $1.54M | ﹤0.01% |
56,140
-19,613
| -26% | -$537K |
|
|
CNR
1640
Core Natural Resources, Inc.
CNR
$3.75B
| $1.54M | ﹤0.01% |
44,887
+5,693
| +15% | +$195K |
|
1641
Flowers Foods
FLO
$2.9B
| $1.53M | ﹤0.01% |
71,583
+60,037
| +520% | +$1.28M |
|
1642
Suncor Energy
SU
$50.6B
| $1.52M | ﹤0.01% |
46,983
-740,637
| -94% | -$24M |
|
|
MR
1643
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.52M | ﹤0.01% |
101,291
+70,105
| +225% | +$1.05M |
|
1644
TTEC Holdings
TTEC
$173M
| $1.52M | ﹤0.01% |
41,988
+15,091
| +56% | +$547K |
|
|
RP
1645
DELISTED
RealPage, Inc.
RP
| $1.52M | ﹤0.01% |
25,042
-19,814
| -44% | -$1.2M |
|
|
VCRA
1646
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.51M | ﹤0.01% |
47,802
-99,664
| -68% | -$3.15M |
|
|
GPX
1647
DELISTED
GP Strategies Corp.
GPX
| $1.51M | ﹤0.01% |
123,848
+434
| +0.4% | +$5.27K |
|
1648
Buckle
BKE
$3.04B
| $1.5M | ﹤0.01% |
80,315
+63,078
| +366% | +$1.18M |
|
|
IMDZ
1649
DELISTED
Immune Design Corp.
IMDZ
| $1.5M | ﹤0.01% |
257,007
+51,859
| +25% | +$303K |
|
|
INSY
1650
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.5M | ﹤0.01% |
324,957
-187,487
| -37% | -$866K |
|